08.24.2019 Issue 182

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

 Entry-Level Market Access Communications Writer

Evidera’s Market Access Communications team interprets and communicates the clinical and economic evidence that our pharmaceutical/life sciences clients require to successfully market their products.

Head of Health Economic Modelling

Associate Research Director (PS24632)

Market Access Writer 1 (Entry Level) London

Associate Director/Lead Market Access Writer

Lead Market Access Writer

Senior Research Analyst – Outcomes Research

Senior Research Analyst – Outcomes Research – HEOR


Tufts Health Plan, Harvard Pilgrim to Merge

White Paper Dives into Social Determinants of Health

Podcast Spotlights RWE in Drug Development

FDA’s OCE, Syapse Partner on RWE

Report: Trump Administration Moving Forward with International Pricing Index

Industry Spotlight


Conferences Webinars
Identifying Evidence for NICE Economic Submissions
    September 5, York, England

RISE West 2019
    September 9-11, San Diego, California

2019 NASP Annual Meeting and Expo
    September 9-12, Washington, D.C.

Integrating Innovative Genetic Testing Into the Pharmacy Decision-Making Process
    August 29

ICER’s Value Framework and Patient Feedback: Q&A with Steve Pearson
    September 4

Predictive Analytics - Identifying Tomorrow's Challenges Today
    September 18


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026

Biosimilars: US Payer Insights (2019)

Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Social Determinants of Health: The Impact on Members, Health Outcomes and the Bottom Line

Leveraging Technology to Reduce Costs in Clinical Trials

Evidence Generation and Communication

Medical Cost Trend: Behind the Numbers 2020

Harnessing the Power of Nontraditional Data in Health Care

Global Oncology Trends 2019


Special Thanks to Our Partners:
      Precision Xtract             Truven         
              Evidera    HealthCore    University of FL
      Xcenda    OM1    Parexel    Jefferson    Dymaxium    
         Pharmerit    eMax Health    Evidence Partners
       ICON